Dutch startup Arceon is working with industry leaders to test its Carbeon CMC, targeting UHTCMC and a presence in the U.S. in ...

The most important thing to understand about the PIP claims process is that awards are based on how your condition, long-term illness or disability affects you - not the actual condition itself. The ...

The most important thing to understand about the PIP claims process is that awards are based on how your condition, long-term illness or disability affects you - not the actual condition itself.

The Department for Work and Pensions (DWP) have shared important updates on Personal Independence Payment (PIP) waiting times for people due an award review. Minister for Social Security and ...

A PIP warning has been issued to thousands of claimants ... Payment to help with the extra costs of disabilities and long-term health conditions, with thousands more applying for the support ...

This means that many older people who already rely on PIP to manage the extra costs of disability or long-term illness could keep receiving support even after they qualify for their state pension.

The decision to have a stem cell transplant was one I had to think long and ... such a new treatment. But the results we do have suggest this type of treatment is potentially a cure for sickle ...

Pepfar, which is estimated to have delivered lifesaving treatment to as many as 25 million people in 54 countries, faces a ...

“And talking… the words totally disappear… understanding that as a patient, yes there are side effects around treatment, but actually there are more long-term side effects.” Kate also said ...

panelist discusses how polycythemia vera (PV) treatment approaches include both therapeutic phlebotomy ... symptoms and cardiovascular risk factors to achieve both immediate symptom relief and ...

Food insecurity and malnutrition in cancer patients can lead to poor treatment outcomes, including increased hospital ... in an interview with CURE®. In the interview, Arthur delved into insights on ...

but improved with treatment. Some people experienced relief for a relatively short window of time, indicating to researchers Paxlovid is not a cure-all for everyone with long Covid. A 40-year-old ...